Literature DB >> 29866868

Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages.

Dina Coertzen1, Janette Reader1, Mariëtte van der Watt1, Sindisiwe H Nondaba1, Liezl Gibhard2, Lubbe Wiesner2, Peter Smith2, Sarah D'Alessandro3, Donatella Taramelli3, Ho Ning Wong4, Jan L du Preez4, Ronald Wai Keung Wu5, Lyn-Marie Birkholtz6, Richard K Haynes7.   

Abstract

The emergence of resistance toward artemisinin combination therapies (ACTs) by the malaria parasite Plasmodium falciparum has the potential to severely compromise malaria control. Therefore, the development of new artemisinins in combination with new drugs that impart activities toward both intraerythrocytic proliferative asexual and transmissible gametocyte stages, in particular, those of resistant parasites, is urgently required. We define artemisinins as oxidant drugs through their ability to oxidize reduced flavin cofactors of flavin disulfide reductases critical for maintaining redox homeostasis in the malaria parasite. Here we compare the activities of 10-amino artemisinin derivatives toward the asexual and gametocyte stages of P. falciparum parasites. Of these, artemisone and artemiside inhibited asexual and gametocyte stages, particularly stage V gametocytes, in the low-nanomolar range. Further, treatment of both early and late gametocyte stages with artemisone or artemiside combined with the pro-oxidant redox partner methylene blue displayed notable synergism. These data suggest that modulation of redox homeostasis is likely an important druggable process, particularly in gametocytes, and this finding thereby enhances the prospect of using combinations of oxidant and redox drugs for malaria control.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Plasmodium falciparum; artemisinins; gametocytes; oxidative stress; reactive oxygen species; synergism

Mesh:

Substances:

Year:  2018        PMID: 29866868      PMCID: PMC6105806          DOI: 10.1128/AAC.02214-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  94 in total

Review 1.  A medicinal chemistry perspective on artemisinin and related endoperoxides.

Authors:  Paul M O'Neill; Gary H Posner
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

2.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 3.  Methylene blue as an antimalarial agent.

Authors:  R Heiner Schirmer; Boubacar Coulibaly; August Stich; Michael Scheiwein; Heiko Merkle; Jana Eubel; Katja Becker; Heiko Becher; Olaf Müller; Thomas Zich; Wolfgang Schiek; Bocar Kouyaté
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

Review 4.  Iron and heme metabolism in Plasmodium falciparum and the mechanism of action of artemisinins.

Authors:  Nectarios Klonis; Darren J Creek; Leann Tilley
Journal:  Curr Opin Microbiol       Date:  2013-08-07       Impact factor: 7.934

Review 5.  Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.

Authors:  Richard K Haynes; Kwan-Wing Cheu; David N'Da; Paolo Coghi; Diego Monti
Journal:  Infect Disord Drug Targets       Date:  2013-08

6.  Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.

Authors:  Aurélie Pascual; Marilyn Madamet; Sébastien Briolant; Tiphaine Gaillard; Rémy Amalvict; Nicolas Benoit; Dominique Travers; Bruno Pradines
Journal:  Malar J       Date:  2015-02-05       Impact factor: 2.979

7.  Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination.

Authors:  Janette Reader; Mariëtte Botha; Anjo Theron; Sonja B Lauterbach; Claire Rossouw; Dewaldt Engelbrecht; Melanie Wepener; Annél Smit; Didier Leroy; Dalu Mancama; Theresa L Coetzer; Lyn-Marie Birkholtz
Journal:  Malar J       Date:  2015-05-22       Impact factor: 2.979

8.  A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes.

Authors:  Martijn W Vos; Will J R Stone; Karin M Koolen; Geert-Jan van Gemert; Ben van Schaijk; Didier Leroy; Robert W Sauerwein; Teun Bousema; Koen J Dechering
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

9.  pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.

Authors:  Colin J Sutherland; Paul Lansdell; Mandy Sanders; Julian Muwanguzi; Donelly A van Schalkwyk; Harparkash Kaur; Debbie Nolder; Julie Tucker; Hayley M Bennett; Thomas D Otto; Matthew Berriman; Trupti A Patel; Roderick Lynn; Effrossyni Gkrania-Klotsas; Peter L Chiodini
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

10.  Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.

Authors:  Augustin Zoungrana; Boubacar Coulibaly; Ali Sié; Ingeborg Walter-Sack; Frank P Mockenhaupt; Bocar Kouyaté; R Heiner Schirmer; Christina Klose; Ulrich Mansmann; Peter Meissner; Olaf Müller
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more
  16 in total

1.  Naphthylisoquinoline alkaloids, validated as hit multistage antiplasmodial natural products.

Authors:  Phanankosi Moyo; William Shamburger; Mariëtte E van der Watt; Janette Reader; Ana Carolina C de Sousa; Timothy J Egan; Vinesh J Maharaj; Gerhard Bringmann; Lyn-Marie Birkholtz
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-05-24       Impact factor: 4.077

Review 2.  Enhancing the antimalarial activity of artesunate.

Authors:  J O Adebayo; H Tijjani; A P Adegunloye; A A Ishola; E A Balogun; S O Malomo
Journal:  Parasitol Res       Date:  2020-07-07       Impact factor: 2.289

3.  Bioassay-guided isolation and identification of gametocytocidal compounds from Artemisia afra (Asteraceae).

Authors:  Phanankosi Moyo; Phaladi Kunyane; Mamoalosi A Selepe; Jacobus N Eloff; Jandeli Niemand; Abraham I Louw; Vinesh J Maharaj; Lyn-Marie Birkholtz
Journal:  Malar J       Date:  2019-03-08       Impact factor: 2.979

4.  Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.

Authors:  Barbara H Stokes; Euna Yoo; James M Murithi; Madeline R Luth; Pavel Afanasyev; Paula C A da Fonseca; Elizabeth A Winzeler; Caroline L Ng; Matthew Bogyo; David A Fidock
Journal:  PLoS Pathog       Date:  2019-06-06       Impact factor: 6.823

5.  Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage P. falciparum Including PfKI3 C580Y Mutants and Liver Stage P. berghei Parasites.

Authors:  Ho Ning Wong; Vivian Padín-Irizarry; Mariëtte E van der Watt; Janette Reader; Wilna Liebenberg; Lubbe Wiesner; Peter Smith; Korina Eribez; Elizabeth A Winzeler; Dennis E Kyle; Lyn-Marie Birkholtz; Dina Coertzen; Richard K Haynes
Journal:  Front Chem       Date:  2020-01-10       Impact factor: 5.221

6.  Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells.

Authors:  Ghizal Siddiqui; Carlo Giannangelo; Amanda De Paoli; Anna Katharina Schuh; Kim C Heimsch; Dovile Anderson; Timothy G Brown; Christopher A MacRaild; Jianbo Wu; Xiaofang Wang; Yuxiang Dong; Jonathan L Vennerstrom; Katja Becker; Darren J Creek
Journal:  ACS Infect Dis       Date:  2022-01-05       Impact factor: 5.084

7.  Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether.

Authors:  Daniel J Watson; Lizahn Laing; Liezl Gibhard; Ho Ning Wong; Richard K Haynes; Lubbe Wiesner
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

Review 8.  Liposomes for malaria management: the evolution from 1980 to 2020.

Authors:  Patrick B Memvanga; Christian I Nkanga
Journal:  Malar J       Date:  2021-07-27       Impact factor: 2.979

9.  The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside.

Authors:  Liezl Gibhard; Dina Coertzen; Janette Reader; Mariëtte E van der Watt; Lyn-Marie Birkholtz; Ho Ning Wong; Kevin T Batty; Richard K Haynes; Lubbe Wiesner
Journal:  Pharmaceutics       Date:  2021-12-03       Impact factor: 6.321

10.  Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy.

Authors:  Lloyd Tanner; Gabriel T Mashabela; Charles C Omollo; Timothy J de Wet; Christopher J Parkinson; Digby F Warner; Richard K Haynes; Lubbe Wiesner
Journal:  Microbiol Spectr       Date:  2021-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.